GlassScriptPhysician profile
Titus Duncan
NPI 1366480402
$5,010.10
in general payments reported to CMS, 2019-2025
15 companies · $18.25 in 2025
The $18.25 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,153 · 2021: $30.98 · 2022: $483 · 2023: $1,325 · 2025: $18.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $776 · Food and Beverage: $567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $776.38 |
| Food and Beverage | $567.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,894.59 | 2019 | |
| Medical Device Business Services, INC. | $1,070.02 | 2019 | |
| Apollo Endosurgery US INC | $953.21 | 2023 | Overstitch Endoscopic Suturing System |
| Reshape Lifesciences INC. | $363.81 | 2022-2023 | |
| Medtronic, INC. | $170.62 | 2023 | Signia |
| Ethicon US, LLC | $105.70 | 2019 | |
| Baxter Healthcare | $77.72 | 2022 | |
| Novo Nordisk INC | $74.60 | 2023 | Wegovy |
| Lexington Medical, INC. | $63.40 | 2022 | |
| Covidien LP | $63.03 | 2019 | |
| Hologic Sales and Service, LLC | $62.37 | 2023 | Coolseal Generator |
| Lucid Diagnostics INC. | $42.33 | 2023 | |
| Teleflex LLC | $30.98 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $19.47 | 2019 | |
| Glaxosmithkline, LLC. | $18.25 | 2025 | Benlysta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Titus Duncan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.